Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 von Sureda, A, Bader, P, Cesaro, S, Dreger, P, Duarte, R F, Dufour, C, Falkenburg, J H F, Farge-Bancel, D, Gennery, A, Kröger, N, Lanza, F, Marsh, J C, Nagler, A, Peters, C, Velardi, A, Mohty, M, Madrigal, A

Volltext

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma von Franssen, L E, Roeven, M W H, Hobo, W, Doorn, R, Oostvogels, R, Falkenburg, J H F, van de Donk, N W, Kester, M G D, Fredrix, H, Westinga, K, Slaper-Cortenbach, I, Spierings, E, Kersten, M J, Dolstra, H, Mutis, T, Schaap, N, Lokhorst, H M

Volltext

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT von Noviello, Maddalena, Manfredi, Francesco, Ruggiero, Eliana, Perini, Tommaso, Oliveira, Giacomo, Cortesi, Filippo, De Simone, Pantaleo, Toffalori, Cristina, Gambacorta, Valentina, Greco, Raffaella, Peccatori, Jacopo, Casucci, Monica, Casorati, Giulia, Dellabona, Paolo, Onozawa, Masahiro, Teshima, Takanori, Griffioen, Marieke, Halkes, Constantijn J. M., Falkenburg, J. H. F., Stölzel, Friedrich, Altmann, Heidi, Bornhäuser, Martin, Waterhouse, Miguel, Zeiser, Robert, Finke, Jürgen, Cieri, Nicoletta, Bondanza, Attilio, Vago, Luca, Ciceri, Fabio, Bonini, Chiara

Volltext

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants von Passweg, J R, Baldomero, H, Bader, P, Bonini, C, Cesaro, S, Dreger, P, Duarte, R F, Dufour, C, Falkenburg, J H F, Farge-Bancel, D, Gennery, A, Kröger, N, Lanza, F, Nagler, A, Sureda, A, Mohty, M

Volltext

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL von Eefting, M, Halkes, C J M, de Wreede, L C, van Pelt, C M, Kersting, S, Marijt, E W A, von dem Borne, P A, Willemze, R, Veelken, H, Falkenburg, J H F

Volltext

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation von Passweg, J R, Baldomero, H, Peters, C, Gaspar, H B, Cesaro, S, Dreger, P, Duarte, R F, Falkenburg, J H F, Farge-Bancel, D, Gennery, A, Halter, J, Kröger, N, Lanza, F, Marsh, J, Mohty, M, Sureda, A, Velardi, A, Madrigal, A

Volltext

Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies von Pont, M J, Honders, M W, Kremer, A N, van Kooten, C, Out, C, Hiemstra, P S, de Boer, H C, Jager, M J, Schmelzer, E, Vries, R G, Al Hinai, A S, Kroes, W G, Monajemi, R, Goeman, J J, Böhringer, S, Marijt, W A F, Falkenburg, J H F, Griffioen, M

Volltext

Hematopoietic SCT in Europe: data and trends in 2011 von Passweg, J R, Baldomero, H, Bregni, M, Cesaro, S, Dreger, P, Duarte, R F, Falkenburg, J H F, Kröger, N, Farge-Bancel, D, Bobby Gaspar, H, Marsh, J, Mohty, M, Peters, C, Sureda, A, Velardi, A, Ruiz de Elvira, C, Madrigal, A

Volltext

Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy von Luk, S. J., IJsselsteijn, M. E., Somarakis, A., Acem, I., de Bruijn, I. Briaire, Szuhai, K., Bovee, J. V. M. G., de Miranda, N. F. C. C., Falkenburg, J. H. F., Heemskerk, M. H. M.

Volltext

Allo-reactive T cells for the treatment of hematological malignancies von Falkenburg, J.H.F., Jedema, I.

Volltext

HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia von Rutten, C E, van Luxemburg-Heijs, S A P, Griffioen, M, Marijt, E W A, Jedema, I, Heemskerk, M H M, Posthuma, E F M, Willemze, R, Falkenburg, J H F

Volltext

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical St... von van Balen, Peter, Jedema, Inge, van Loenen, Marleen M, de Boer, Renate, van Egmond, H M, Hagedoorn, Renate S, Hoogstaten, Conny, Veld, Sabrina A J, Hageman, Lois, van Liempt, P A G, Zwaginga, Jaap-Jan, Meij, Pauline, Veelken, H, Falkenburg, J H F, Heemskerk, Mirjam H M

Volltext

Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients von van der Zouwen, Boris, Koster, E. A. S., von dem Borne, P. A., Oosten, L. E. M., Roza-Scholten, M. W. I., Snijders, T. J. F., van Lammeren, D., van Balen, P., Marijt, W. A. F., Veelken, H., Falkenburg, J. H. F., de Wreede, L. C., Halkes, C. J. M.

Volltext

T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens von Jolink, H., Boer, R., Willems, L. N. A., Dissel, J. T., Falkenburg, J. H. F., Heemskerk, M. H. M.

Volltext

Donor T-cell responses and disease progression patterns of multiple myeloma von Eefting, M, de Wreede, L C, Von dem Borne, P A, Halkes, C J M, Kersting, S, Marijt, E W A, Putter, H, Veelken, H, Schetelig, J, Falkenburg, J H F

Volltext

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T... von van Balen, Peter, van der Zouwen, Boris, Kruisselbrink, Alwine B, Eefting, Matthijs, Szuhai, Karoly, Jordanova, Ekaterina S, Falkenburg, J H F, Jedema, Inge

Volltext

Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia von Stevanović, S, Griffioen, M, Nijmeijer, B A, van Schie, M L J, Stumpf, A N, Rutten, C E, Willemze, R, Falkenburg, J H F

Volltext

Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity von Jedema, I, Barge, R M Y, van der Velden, V H J, Nijmeijer, B A, van Dongen, J J M, Willemze, R, Falkenburg, J H F

Volltext

Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells von van Loenen, M M, de Boer, R, Hagedoorn, R S, Jankipersadsing, V, Amir, A L, Falkenburg, J H F, Heemskerk, M H M

Volltext

Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell trans... von Eefting, Matthias, von dem Borne, Peter A, de Wreede, Liesbeth C, Halkes, Constantijn J M, Kersting, Sabina, Marijt, Erik W A, Veelken, Hendrik, Falkenburg, Jh Frederik

Volltext